Europe Oligonucleotide Synthesis Reagents Market Size & Outlook
The oligonucleotide synthesis reagents market in Europe is expected to reach a projected revenue of US$ 478.6 million by 2033. A compound annual growth rate of 10.7% is expected of Europe oligonucleotide synthesis reagents market from 2026 to 2033.
Revenue, 2025 (US$M)
$214.2
Estimate, 2026 (US$M)
$234.7
Forecast, 2033 (US$M)
$478.6
CAGR, 2026 - 2033
10.7%
Global Market
Related Markets
Europe oligonucleotide synthesis reagents market highlights
- The Europe oligonucleotide synthesis reagents market generated a revenue of USD 214.2 million in 2025.
- The market is expected to grow at a CAGR of 10.7% from 2026 to 2033.
- In terms of segment, core synthesis reagents was the largest revenue generating product in 2025.
- Modification reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 214.2 million |
| Market revenue in 2033 | USD 478.6 million |
| Growth rate | 10.7% (CAGR from 2026 to 2033) |
| Largest segment | Core synthesis reagents |
| Fastest growing segment | Modification reagents |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Core synthesis reagents, Process reagents, Modification reagents, Purification-related reagents, Others Product |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.6% of the global oligonucleotide synthesis reagents market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 467.6 million by 2033.
No credit card required*
Publish Date: Apr 21, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Oligonucleotide Synthesis Reagents Market Scope
Oligonucleotide Synthesis Reagents Market segmentation & scope
Oligonucleotide Synthesis Reagents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Tokyo Chemical Industry | View profile | 501-1000 | Chennai, Tamil Nadu, India, Asia | www.tcichemicals.com/ |
| Twist Bioscience Corp | View profile | 919 | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 | www.twistbioscience.com |
| Bio-Synthesis | View profile | 11-50 | Seminole, Texas, United States, North America | www.biosyn.com |
| Biolegio | View profile | 11-50 | Nijmegen, Gelderland, The Netherlands, Europe | www.biolegio.com |
| Agilent Technologies, Inc. | View profile | - | - | - |
| Thermo Fisher Scientific Inc. | View profile | - | - | - |
Europe Oligonucleotide Synthesis Reagents Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oligonucleotide Synthesis Reagents Market Outlook will help companies and investors design strategic landscapes.
Core Synthesis Reagents was the largest segment with a revenue share of 35.34% in 2025.
Horizon Databook has segmented the Europe oligonucleotide synthesis reagents market based on core synthesis reagents, process reagents, modification reagents, purification-related reagents, others product covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Oligonucleotide Synthesis Reagents Market Product Outlook (Revenue, USD Million , 2021-2033)
- Core synthesis reagents
- Process reagents
- Modification reagents
- Purification-related reagents
- Others Product
- Europe Oligonucleotide Synthesis Reagents Market Application Outlook (Revenue, USD Million , 2021-2033)
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Other Applications
- Europe Oligonucleotide Synthesis Reagents Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
Reasons to subscribe to Oligonucleotide Synthesis Reagents Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oligonucleotide Synthesis Reagents Market Outlook databook
- Our clientele includes a mix of Oligonucleotide Synthesis Reagents Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Oligonucleotide Synthesis Reagents Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Oligonucleotide Synthesis Reagents Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Oligonucleotide Synthesis Reagents Market, 2021-2033 (US$M)
Europe oligonucleotide synthesis reagents market statistics, by product, 2021-2033 (US$M)
